7.22
price up icon0.56%   0.04
after-market 시간 외 거래: 7.25 0.03 +0.42%
loading
전일 마감가:
$7.18
열려 있는:
$7.18
하루 거래량:
2.32M
Relative Volume:
1.55
시가총액:
$844.81M
수익:
-
순이익/손실:
$-242.30M
주가수익비율:
-2.9113
EPS:
-2.48
순현금흐름:
$-192.10M
1주 성능:
-0.28%
1개월 성능:
+32.72%
6개월 성능:
-7.44%
1년 성능:
-19.24%
1일 변동 폭
Value
$7.07
$7.465
1주일 범위
Value
$7.03
$7.50
52주 변동 폭
Value
$3.72
$12.61

코젠트 바이오사이언시스 Stock (COGT) Company Profile

Name
명칭
Cogent Biosciences Inc
Name
전화
617-945-5576
Name
주소
275 WYMAN STREET, WALTHAM
Name
직원
205
Name
트위터
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
COGT's Discussions on Twitter

COGT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
COGT
Cogent Biosciences Inc
7.22 844.81M 0 -242.30M -192.10M -2.48
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

코젠트 바이오사이언시스 Stock (COGT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-07 개시 Scotiabank Sector Outperform
2024-12-11 다운그레이드 Needham Buy → Hold
2024-02-26 다운그레이드 Robert W. Baird Outperform → Neutral
2024-02-08 개시 Citigroup Buy
2023-12-11 다운그레이드 Wedbush Outperform → Neutral
2023-12-08 개시 JP Morgan Overweight
2023-04-28 개시 Robert W. Baird Outperform
2023-03-27 재개 H.C. Wainwright Buy
2022-12-14 개시 Needham Buy
2022-06-28 개시 Guggenheim Buy
2021-10-11 개시 H.C. Wainwright Buy
2021-06-09 재개 Jefferies Buy
2020-12-23 개시 Piper Sandler Overweight
2020-10-14 개시 Ladenburg Thalmann Buy
모두보기

코젠트 바이오사이언시스 주식(COGT)의 최신 뉴스

pulisher
Jun 18, 2025

(COGT) Investment Analysis - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 18, 2025

Cogent Biosciences (NASDAQ:COGT) Given “Hold” Rating at Needham & Company LLC - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Cogent Biosciences (COGT) Receives Reiterated 'Hold' Rating by N - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Cogent Biosciences (COGT) Receives Reiterated 'Hold' Rating by Needham | COGT Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Brokerages Set Cogent Biosciences, Inc. (NASDAQ:COGT) Target Price at $14.57 - Defense World

Jun 16, 2025
pulisher
Jun 14, 2025

Bank of America Corp DE Reduces Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Cogent Biosciences Term Loan Facility - Leerink Partners

Jun 12, 2025
pulisher
Jun 12, 2025

Cogent Biosciences, Inc. (NASDAQ:COGT) Stock Position Lowered by California State Teachers Retirement System - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Latham & Watkins Leads on US$400 Million Debt Financing Facility for Cogent Biosciences - Latham & Watkins LLP

Jun 12, 2025
pulisher
Jun 11, 2025

Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Cogent Biosciences Secures $400 Million in Financing - citybiz

Jun 11, 2025
pulisher
Jun 11, 2025

Cogent Biosciences, Inc. announced that it expects to receive $400 million in funding - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Cogent Biosciences Gets $400 Million Debt Financing - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Cogent Biosciences (COGT) Secures $400M Financing for Growth Ini - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cogent Secures Up To $400 Mln Debt Facility From SLR Capital For Growth Strategy - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Cogent Biosciences Secures $400 Million Debt Financing Facility to Support Growth and Upcoming Bezuclastinib Launch - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Cogent Biosciences Lands Massive $400M Financing Deal as 3 Pivotal Trial Results Loom in 2025 - Stock Titan

Jun 11, 2025
pulisher
Jun 10, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 17,741 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail

Jun 10, 2025
pulisher
Jun 08, 2025

Two Sigma Investments LP Sells 4,633 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Two Sigma Advisers LP Has $148,000 Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Ameriprise Financial Inc. Acquires 9,459 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

(COGT) On The My Stocks Page - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 03, 2025

Nuveen Asset Management LLC Has $2.44 Million Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Jun 03, 2025
pulisher
Jun 01, 2025

ProShare Advisors LLC Increases Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Jun 01, 2025
pulisher
Jun 01, 2025

Cogent Biosciences (NASDAQ:COGT) Trading Down 5.7% – Time to Sell? - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $25.00 at JPMorgan Chase & Co. - Defense World

May 30, 2025
pulisher
May 30, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

May 30, 2025
pulisher
May 30, 2025

Cogent Biosciences (NASDAQ:COGT) Shares Up 11.6% Following Analyst Upgrade - Defense World

May 30, 2025
pulisher
May 29, 2025

COGT: JP Morgan Raises Price Target for Cogent Biosciences | COG - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Cogent Biosciences Announces Participation in the Jefferies Glob - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference - GlobeNewswire

May 29, 2025
pulisher
May 29, 2025

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference | COGT Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

JPMorgan Ups Price Target for Cogent Biosciences (COGT) to $25 | - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Cogent Biosciences Reveals Latest Precision Therapy Progress Plus New Employee Stock Options - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Deutsche Bank AG Reduces Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

May 29, 2025
pulisher
May 28, 2025

Jane Street Group LLC Decreases Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

May 28, 2025
pulisher
May 27, 2025

This Cogent Biosciences Insider Increased Their Holding By 2,085% Last Year - simplywall.st

May 27, 2025
pulisher
May 26, 2025

When (COGT) Moves Investors should Listen - news.stocktradersdaily.com

May 26, 2025
pulisher
May 25, 2025

BNP Paribas Financial Markets Buys Shares of 66,784 Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

May 25, 2025
pulisher
May 25, 2025

Janus Henderson Group PLC Has $227,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

May 25, 2025
pulisher
May 23, 2025

Q2 EPS Estimate for Cogent Biosciences Raised by Analyst - Defense World

May 23, 2025
pulisher
May 22, 2025

HC Wainwright Has Lowered Expectations for Cogent Biosciences (NASDAQ:COGT) Stock Price - Defense World

May 22, 2025
pulisher
May 22, 2025

Brokerages Set Cogent Biosciences, Inc. (NASDAQ:COGT) PT at $14.29 - Defense World

May 22, 2025
pulisher
May 20, 2025

Cogent Biosciences (COGT) Maintains 'Buy' Rating with Adjusted P - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Cogent Biosciences (COGT) Maintains 'Buy' Rating with Adjusted Price Target | COGT Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Cogent Biosciences (COGT) Price Target Reduced by H.C. Wainwrigh - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Northern Trust Corp Grows Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

May 20, 2025
pulisher
May 16, 2025

Where are the Opportunities in (COGT) - news.stocktradersdaily.com

May 16, 2025
pulisher
May 15, 2025

Price T Rowe Associates Inc. MD Has $388,000 Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

May 15, 2025
pulisher
May 14, 2025

Wall Street Analysts Believe Cogent Biosciences (COGT) Could Rally 224.37%: Here's is How to Trade - MSN

May 14, 2025

코젠트 바이오사이언시스 (COGT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):